Effect of fluticasone furoate and vilanterol on exacerbations of chronic obstructive pulmonary disease in patients with moderate airflow obstruction Academic Article uri icon

Overview

MeSH Major

  • Androstadienes
  • Benzyl Alcohols
  • Chlorobenzenes
  • Pulmonary Disease, Chronic Obstructive

abstract

  • Patients with moderate chronic airflow obstruction experienced a reduction in exacerbations with FF/VI compared with placebo, irrespective of a history of exacerbations or baseline FEV1. Clinical trial registered with www.clinicaltrials.gov (NCT 01313676; GSK Study number 113782).

publication date

  • April 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1164/rccm.201607-1421OC

PubMed ID

  • 27767328

Additional Document Info

start page

  • 881

end page

  • 888

volume

  • 195

number

  • 7